Literature DB >> 15336568

Thermal inactivation of protective antigen of Bacillus anthracis and its prevention by polyol osmolytes.

Samer Singh1, Aparna Singh, Mohd Azhar Aziz, Syed Mohsin Waheed, Rajiv Bhat, Rakesh Bhatnagar.   

Abstract

Protective antigen (PA) of Bacillus anthracis is the main immunogen of all anthrax vaccines. It is a highly thermolabile molecule and loses its activity rapidly when exposed to higher temperatures. Earlier some cosolvents had been used to stabilize PA with variable success but no study has been done to find out the primary cause of PA thermal inactivation. This study aims at elucidating the predominant cause of thermal inactivation of PA in order to develop more effective strategies for its thermostabilization. The prime cause for the loss of biological activity of PA at high temperature was its aggregation and an inverse correlation between PA activity and its aggregation on heating was observed. Inactivation of the protein by autolysis did not occur. This paper reports the use of a series of polyol osmolytes to stabilize PA. Different polyols stabilized PA to a different extent against thermal inactivation in a concentration dependent manner, with glycerol stabilizing to the maximum extent. Addition of NaCl to glycerol solution further enhanced the thermal stability of PA. An increase in the T(1/2) value, the temperature at which 50% of the activity is retained during short-term incubation, of more than 20 degrees C was observed. The half-life (t(1/2)) of PA thermal inactivation at 40 degrees C increased by more than 6 times in the presence of the mixture of glycerol and NaCl as compared to control. This study demonstrates for the first time that aggregation of the PA molecule is the predominant cause of its thermal inactivation, and can be very effectively prevented by the use of glycerol and other polyols to increase the shelf life of the recombinant vaccine against anthrax.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15336568     DOI: 10.1016/j.bbrc.2004.08.020

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Reduction of immunogenicity of anthrax vaccines subjected to thermal stress, as measured by a toxin neutralization assay.

Authors:  Juan Castelán-Vega; Laura Corvette; Lev Sirota; Juan Arciniega
Journal:  Clin Vaccine Immunol       Date:  2010-12-08

2.  Amphiphilic polyanhydride nanoparticles stabilize Bacillus anthracis protective antigen.

Authors:  L K Petersen; Y Phanse; A E Ramer-Tait; M J Wannemuehler; B Narasimhan
Journal:  Mol Pharm       Date:  2012-03-20       Impact factor: 4.939

3.  Designing Stable Bacillus anthracis Antigens with a View to Recombinant Anthrax Vaccine Development.

Authors:  Ekaterina M Ryabchevskaya; Dmitriy L Granovskiy; Ekaterina A Evtushenko; Peter A Ivanov; Olga A Kondakova; Nikolai A Nikitin; Olga V Karpova
Journal:  Pharmaceutics       Date:  2022-04-06       Impact factor: 6.525

4.  Structural hot spots for the solubility of globular proteins.

Authors:  Ashok Ganesan; Aleksandra Siekierska; Jacinte Beerten; Marijke Brams; Joost Van Durme; Greet De Baets; Rob Van der Kant; Rodrigo Gallardo; Meine Ramakers; Tobias Langenberg; Hannah Wilkinson; Frederik De Smet; Chris Ulens; Frederic Rousseau; Joost Schymkowitz
Journal:  Nat Commun       Date:  2016-02-24       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.